Japanese firm Renascience has concluded a joint research agreement on ageing with Prof. Douglas E. Vaughan, Direct...
Japanese pharmaceutical firm Daiichi Sankyo has established a state-of-the-art research laboratory in San Diego, Ca...
Sumitomo Pharma has concluded a co-promotion collaboration partner agreement with Johnson & Johnson (J&J) in Jap...
Japan headquartered Shimadzu Corporation has released seven new Brevis GC-2050 Systems for the Green Transform...
BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of a new c...
Taiwan-based Advanced Genomics APAC Co. has announced the signing of an exclusive service provider agreement with Cancer...
Japan-based NEC Corporation and Biomy, Inc. have signed a Memorandum of Understanding (MoU) for a joint market...
Japanese firm Kaneka Corporation has acquired 96.8% of shares of EndoStream Medical, an Israeli medical equipment compan...
Japan-based Kaken Pharmaceutical Co. has entered into a license agreement with Johnson & Johnson for the globa...
JCR Pharmaceuticals Co. and Modalis Therapeutics Corporation have validated the initial proof of concept ...
Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immun...
Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a...
Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...
Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with dise...
Texas Medical Center (TMC), in the US, in partnership with Japan-based organisations Mitsui Fudosan Co. and&nb...
Israel-based Teva Pharmaceutical Industries has entered into an agreement with JKI, established by the fund managed and ...
